A new epidemiological analysis by experts in the field has indicated that the number of individuals with dementia may be stabilizing in some Western European countries.
Browsing: Cognitive/neurodegenerative disorders
Researchers have identified a pathway at work within the nuclei of astrocyte cells involved in the regulation of TGF-beta signaling, which may be involved in various brain diseases.
A recent investigation suggests that a drug commonly used to treat liver disease – ursodeoxycholic acid – could slow the progression of Parkinson’s disease.
New research highlights the creation of a six-layered 3D printed structure that mimics the structure of brain tissue.
Recently developed monoclonal antibodies have been demonstrated to successfully target toxic oligomer proteins in both Alzheimer’s and Parkinson’s disease.
Several challenges still remain for the accurate diagnosis of dementia in individuals with Down’s Syndrome even following 40 years of focused research. This review looks at current research to identify genetic and biological measures of Alzheimer’s disease in Down’s Syndrome.
This study investigates the use of five neuropsychological tests to predict cognitive decline.
An early precursor of the amyloid beta peptide, ßCTF, has been found to initiate a number of processes that can lead to the loss of neurons critical for memory formation in early Alzheimer’s disease.
This article discusses the role of the FAD-dependent lysine specific demethylase, KDM1, in brain function, and consequently its potential use as a target for treatments for neurodegenerative disease.